|
Estimated global and regional number of total cancer deaths (thousands) and mortality rate (per 100,000) by age, males, 2000 |
|||||||||
| Region |
Age-group |
||||||||
|
|
|||||||||
| 0–4 |
5–14 |
15–29 |
30–44 |
45–59 |
60–69 |
70–79 |
80+ |
Total |
|
|
|
|||||||||
| Number of deaths (000s) |
|||||||||
| World |
22.6 |
27.4 |
79.9 |
228.3 |
844.8 |
1,121.7 |
1,074.6 |
502.6 |
3,901.9 |
| AfrD |
2.1 |
1.3 |
6.2 |
14.3 |
29.2 |
34.2 |
34.8 |
17.1 |
139.3 |
| AfrE |
2.6 |
1.5 |
9.6 |
20.3 |
33.3 |
36.2 |
36.1 |
17.0 |
156.8 |
| AmrA |
0.3 |
0.6 |
2.3 |
10.5 |
54.0 |
74.5 |
105.8 |
77.1 |
325.1 |
| AmrB |
1.7 |
2.5 |
6.0 |
12.4 |
41.4 |
51.7 |
57.6 |
33.9 |
207.1 |
| AmrD |
0.4 |
0.8 |
1.4 |
2.2 |
5.4 |
7.5 |
9.6 |
5.9 |
33.3 |
| EmrB |
0.7 |
1.2 |
1.9 |
3.0 |
10.0 |
11.6 |
11.6 |
4.8 |
44.9 |
| EmrD |
1.2 |
1.5 |
2.4 |
5.1 |
9.0 |
8.8 |
7.6 |
2.7 |
38.2 |
| EurA |
0.4 |
0.9 |
3.2 |
15.2 |
90.1 |
151.1 |
205.8 |
127.8 |
594.3 |
| EurB1 |
0.4 |
0.7 |
2.1 |
8.7 |
37.2 |
49.5 |
39.9 |
12.1 |
150.5 |
| EurB2 |
0.1 |
0.3 |
0.8 |
2.0 |
4.4 |
6.6 |
3.9 |
0.7 |
18.9 |
| EurC |
0.4 |
1.0 |
3.3 |
13.8 |
70.1 |
101.2 |
73.5 |
15.9 |
279.2 |
| SearB |
1.5 |
2.0 |
4.2 |
11.8 |
45.4 |
48.4 |
35.7 |
12.8 |
161.8 |
| SearD |
6.0 |
6.0 |
15.5 |
31.0 |
88.4 |
148.3 |
106.4 |
48.7 |
450.1 |
| WprA |
0.1 |
0.2 |
0.8 |
3.4 |
29.2 |
52.8 |
67.0 |
44.9 |
198.5 |
| WprB1 |
4.1 |
6.2 |
18.7 |
69.7 |
285.7 |
327.5 |
268.6 |
73.8 |
1,054.3 |
| WprB2 |
0.5 |
0.6 |
1.6 |
4.6 |
11.4 |
11.7 |
10.3 |
7.2 |
47.9 |
| WprB3 |
0.0 |
0.0 |
0.1 |
0.2 |
0.6 |
0.4 |
0.2 |
0.1 |
1.6 |
|
|
|||||||||
| Age-specific mortality rate per 100,000 |
|||||||||
| World |
7.3 |
4.5 |
10.0 |
35.3 |
209.6 |
694.5 |
1,264.5 |
2,095.6 |
128.2 |
| AfrD |
7.6 |
2.9 |
13.5 |
54.6 |
214.0 |
697.7 |
1,607.5 |
3,446.7 |
83.9 |
| AfrE |
9.0 |
3.3 |
20.6 |
78.4 |
258.1 |
824.4 |
1,866.5 |
4,078.5 |
93.5 |
| AmrA |
3.0 |
2.8 |
7.2 |
28.4 |
190.0 |
689.9 |
1,353.3 |
2,286.9 |
213.1 |
| AmrB |
7.4 |
5.4 |
9.6 |
27.1 |
158.5 |
546.5 |
1,139.1 |
2,145.2 |
94.5 |
| AmrD |
9.0 |
8.9 |
13.5 |
36.2 |
158.0 |
583.7 |
1,505.9 |
3,264.8 |
93.6 |
| EmrB |
8.9 |
6.6 |
9.1 |
22.2 |
137.7 |
461.9 |
904.8 |
1,444.8 |
62.1 |
| EmrD |
12.9 |
8.9 |
11.8 |
39.2 |
134.5 |
385.5 |
704.1 |
1,014.3 |
54.8 |
| EurA |
3.4 |
3.6 |
7.7 |
31.7 |
230.9 |
762.6 |
1,576.8 |
2,711.7 |
295.6 |
| EurB1 |
6.3 |
5.0 |
9.7 |
48.8 |
288.5 |
847.1 |
1,225.6 |
1,657.4 |
183.0 |
| EurB2 |
4.8 |
5.6 |
10.9 |
38.8 |
197.1 |
598.0 |
772.0 |
676.4 |
75.0 |
| EurC |
7.0 |
5.6 |
11.6 |
50.4 |
351.0 |
1,001.0 |
1,453.4 |
1,541.1 |
242.3 |
| SearB |
7.0 |
4.9 |
7.3 |
28.0 |
199.0 |
569.2 |
905.5 |
1,264.7 |
82.0 |
| SearD |
7.1 |
3.8 |
8.0 |
22.7 |
113.7 |
516.9 |
792.8 |
1,419.2 |
64.8 |
| WprA |
2.9 |
2.9 |
5.4 |
22.9 |
181.1 |
668.2 |
1,387.3 |
2,603.3 |
270.5 |
| WprB1 |
7.5 |
5.1 |
10.6 |
40.3 |
267.2 |
796.0 |
1,372.3 |
1,729.7 |
151.1 |
| WprB2 |
5.9 |
3.8 |
7.6 |
31.3 |
175.1 |
431.4 |
784.9 |
2,303.2 |
68.1 |
| WprB3 |
5.1 |
5.5 |
7.0 |
29.3 |
162.4 |
329.5 |
476.3 |
1,404.1 |
46.7 |
Shibuya et al. BMC Cancer 2002 2:37 doi:10.1186/1471-2407-2-37 |
|||||||||